Angiogenesis of the endometrium

被引:63
作者
Abulafia, O
Sherer, DM
机构
[1] Albert Einstein Coll Med, Div Maternal Fetal Med, Dept Obstet & Gynecol & Womens Hlth, Montefiore Med Ctr, Bronx, NY 10467 USA
[2] SUNY, Dept Obstet & Gynecol, Brooklyn, NY USA
关键词
D O I
10.1016/S0029-7844(99)00262-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To present current data pertaining to angiogenesis of the endometrium throughout the normal menstrual cycle and in benign and neoplastic diseases of the endometrium. Sources: We conducted a computerized search of MEDLINE, Current Contents, and Index Medicus for relevant studies in the English literature published between January 1966 and October 1998. Study selection: We reviewed all studies that included human and animal models of angiogenesis of normal cyclic endometrium and benign and neoplastic endometrial diseases. Tabulation, Integration, and Results: Angiogenesis is important to cyclic, regenerating endometria and disease processes including dysfunctional uterine bleeding, response to exogenous hormonal treatment, bleeding associated with intrauterine contraceptive devices, uterine leiomyomata, endometriosis, complex endometrial hyperplasia, and endometrial carcinoma. Conclusion: In the future, knowledge of specific angiogenic patterns of various disease processes might improve application of antiangiogenic medications in therapies for benign and neoplastic diseases of the endometrium. (C) 1999 by The American College of Obstetricians and Gynecologists.
引用
收藏
页码:148 / 153
页数:6
相关论文
共 50 条
[1]   The effect of medroxyprogesterone acetate on angiogenesis in complex endometrial hyperplasia [J].
Abulafia, O ;
Triest, WE ;
Adcock, JT ;
Sherer, DM .
GYNECOLOGIC ONCOLOGY, 1999, 72 (02) :193-198
[2]   ANGIOGENESIS IN ENDOMETRIAL HYPERPLASIA AND STAGE-I ENDOMETRIAL CARCINOMA [J].
ABULAFIA, O ;
TRIEST, WE ;
SHERER, DM ;
HANSEN, CC ;
GHEZZI, F .
OBSTETRICS AND GYNECOLOGY, 1995, 86 (04) :479-485
[3]   Expression of the fibroblast growth factor receptor in women with leiomyomas and abnormal uterine bleeding [J].
Anania, CA ;
Stewart, EA ;
Quade, BJ ;
Hill, JA ;
Nowak, RA .
MOLECULAR HUMAN REPRODUCTION, 1997, 3 (08) :685-691
[4]   IMMUNOHISTOCHEMICAL STAINING OF VONWILLEBRAND-FACTOR IN HUMAN ENDOMETRIUM DURING NORMAL MENSTRUAL-CYCLE [J].
AU, CL ;
ROGERS, PAW .
HUMAN REPRODUCTION, 1993, 8 (01) :17-23
[5]   Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J].
Carmeliet, P ;
Ferreira, V ;
Breier, G ;
Pollefeyt, S ;
Kieckens, L ;
Gertsenstein, M ;
Fahrig, M ;
Vandenhoeck, A ;
Harpal, K ;
Eberhardt, C ;
Declercq, C ;
Pawling, J ;
Moons, L ;
Collen, D ;
Risau, W ;
Nagy, A .
NATURE, 1996, 380 (6573) :435-439
[6]   IDENTIFICATION AND LOCALIZATION OF ALTERNATELY SPLICED MESSENGER-RNAS FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR IN HUMAN UTERUS AND ESTROGEN REGULATION IN ENDOMETRIAL CARCINOMA CELL-LINES [J].
CHARNOCKJONES, DS ;
SHARKEY, AM ;
RAJPUTWILLIAMS, J ;
BURCH, D ;
SCHOFIELD, JP ;
FOUNTAIN, SA ;
BOOCOCK, CA ;
SMITH, SK .
BIOLOGY OF REPRODUCTION, 1993, 48 (05) :1120-1128
[7]   THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS [J].
DAMATO, RJ ;
LOUGHNAN, MS ;
FLYNN, E ;
FOLKMAN, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :4082-4085
[8]   Vascular endothelial growth factor messenger ribonucleic acid expression in human ovarian and endometrial cancer [J].
Doldi, N ;
Bassan, M ;
Gulisano, M ;
Broccoli, V ;
Boncinelli, E ;
Ferrari, A .
GYNECOLOGICAL ENDOCRINOLOGY, 1996, 10 (06) :375-382
[9]  
DVORAK HF, 1995, AM J PATHOL, V146, P1029
[10]   Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene [J].
Ferrara, N ;
CarverMoore, K ;
Chen, H ;
Dowd, M ;
Lu, L ;
OShea, KS ;
PowellBraxton, L ;
Hillan, KJ ;
Moore, MW .
NATURE, 1996, 380 (6573) :439-442